| Inhibitor | MicroRNA target gene | Reference |
| Aliskiren |
| ↓ miR-106-5p | EGFR/AKT/mTOR, ACE | [27] | ↓ miR-27a-3p | EGFR/AKT/mTOR, ACE | [26–28, 38] | ↓ miR-18b-5p | EGFR, ACE | [29] | ↓ miR-155 | AT1R | |
| Candesartan |
| ↑ miR-483-3p | AGT, ACE-1, ACE-2, AT2R | [26, 38] | ↓ miR-132/122 | Ang II | [38] | ↓ miR-29b | Col1A, Col3A1 | [26, 38] | ↓ miR-212 | AT2R | |
| Telmisartan |
| ↑ miR-31 | | [30] | ↑ miR-181a | TNFalpha | [30] | ↑ miR-16 | VEGF | [30] | ↑ miR-143/145 | KLF4, KLF6, ACE-2 | [30] | ↓ miR-146a/b | TRAF6, KLF4, TLR4 | [31] |
| Atorvastatin |
| ↓ miR-146a/b | TRAF6, KLF4, TLR4 | [31] | ↓ miR-221/222 | p27, p57 | [50] |
| Enalapril |
| ↑ miR-31 | | [30] | ↑ miR-181a | TNFalpha | [30] | ↑ miR-145 | KLF4, KLF6, ACE-2 | [30] | ↑ miR-16 | VEGF, CCND1, CCND2, CCNE | [30, 47] |
| Captopril |
| ↑ miR-16 | VEGF | [30, 47] | ↑ miR-19b | βMHC | [47, 51] | ↑ miR-20b | | [47] | ↑ miR-93 | | [47] | ↑ miR-106b | | [47] | ↑ miR-223 | | [47] | ↑ miR-423-5p | | [47] |
|
|